Discover 243 paid clinical trials in Lebanon, New Hampshire. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Lebanon has about 15,000 residents and hosts the only National Cancer Institute designated comprehensive cancer centre in New Hampshire. Cancer research leads, including lung, ovarian, melanoma, and sarcoma studies, much of it run through the National Cancer Institute and cooperative groups, with epilepsy and inflammatory bowel disease the most visible non cancer areas.
Filter
2
Filter results
Results: 243
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
for
Ulcerative Colitis, Obesity or Overweight
Location: Lebanon NH, Providence RI, Montreal, New Bedford MA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937086
Phase 3, Recruiting
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
for
Crohn's Disease, Obesity or Overweight
Location: Lebanon NH, Providence RI, Montreal, New Bedford MA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937099
Phase 3, Recruiting
Bioimpedance for Ortho Trauma
for
Trauma Injury
Location: Lebanon NH
Sponsor: Dartmouth-Hitchcock Medical Center
Sex: All
Age: 18+
Code: NCT06858488
Recruiting
Long-term Characterization of GOREĀ® TAGĀ® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance